Quidel is an American manufacturer of diagnostics testings that can be used to diagnose infectious diseases as well as cardiovascular and metabolic diseases.
A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations.
FTDs for US listed companies are reported to the SEC and published twice a month.
Therefore there is a certain delay between the reporting and the publishing of the data.
Failures to deliver for QuidelOrtho (QDEL) - 3 months history
Number of shares, 3 months chart
Biweekly Failures to deliver volume for QuidelOrtho (QDEL) - since 2022
Volume in USD (price x number of shares), data since 2022
QuidelOrtho (QDEL) Failure to deliver volume, Year over Year
Year
Volume (Price x Shares)
Change
2024
$4.48 M
-93.13%
2023
$65.3 M
6.06%
2022
$61.56 M
FTD volume in the last 3 months for similar companies or competitors